Advances in understanding molecular determinants in FeLV pathology

Veterinary Immunology and Immunopathology

Volumn 123, Issue 1-2, 2008, Pages 14-22

  Levy, Laura S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Feline leukemia virus; Lymphoma; Oncogenesis; Pathogenesis

Indexed keywords

ANEMIA; CARCINOGENESIS; CAT; DISEASE COURSE; FELINE LEUKEMIA VIRUS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; LYMPHOMA; MURINE LEUKEMIA VIRUS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; REVIEW; SUPERINFECTION; T CELL LYMPHOMA; T LYMPHOCYTE; THYMUS LYMPHOMA; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; CAT DISEASES; CATS; LEUKEMIA VIRUS, FELINE; MUTATION; RETROVIRIDAE INFECTIONS; SELECTION (GENETICS); TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

ANIMALIA; FELINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS;

EID: 43049162148     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.01.008     Document Type: Review

References (47)

1. Athas G.B., Choi B., Prabhu S., Lobelle-Rich P.A., and Levy L.S. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 214 (1995) 431-438
2. Athas G.B., Lobelle-Rich P., and Levy L.S. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J. Virol. 69 (1995) 3324-3332
3. Baier R., Bondeva T., Klinger R., Bondev A., and Wetzker R. Retinoic acid induces selective expression of phosphoinositide 3-kinase gamma in myelomonocytic U937 cells. Cell Growth Differ. 10 (1999) 447-456
4. Battini J.L., Danos O., and Heard J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69 (1995) 713-719
5. Battini J.L., Heard J.M., and Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66 (1992) 1468-1475
6. Boomer S., Eiden M., Burns C.C., and Overbaugh J. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 71 (1997) 8116-8123
7. Brock C., Schaefer M., Reusch H.P., Czupalla C., Michalke M., Spicher K., Schultz G., and Nurnberg B. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J. Cell Biol. 160 (2003) 89-99
8. Brojatsch J., Kristal B.S., Viglianti G.A., Khiroya R., Hoover E.A., and Mullins J.I. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8457-8461
9. Chandhasin C., Coan P.N., and Levy L.S. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J. Virol. 79 (2005) 1351-1360
10. Chandhasin C., Coan P.N., Pandrea I., Grant C.K., Lobelle-Rich P.A., Puetter A., and Levy L.S. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J. Virol. 79 (2005) 5278-5287
11. Chandhasin C., Lobelle-Rich P.A., and Levy L.S. Feline leukemia virus LTR variation and disease association in a geographic and temporal cluster. J. Gen. Virol. 85 (2004) 2937-2942
12. Donahue P.R., Hoover E.A., Beltz G.A., Riedel N., Hirsch V.M., Overbaugh J., and Mullins J.I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62 (1988) 722-731
13. Donahue P.R., Quackenbush S.L., Gallo M.V., deNoronha C.M., Overbaugh J., Hoover E.A., and Mullins J.I. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 65 (1991) 4461-4469
14. Fan H. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 5 (1997) 74-82
15. Finstad S.L., Prabhu S., Rulli K.R., and Levy L.S. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR. Virol. J. (Biomed. Central) 1 (2004) 3
16. Fulton R., Plumb M., Shield L., and Neil J.C. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J. Virol. 64 (1990) 1675-1682
17. Gwynn S.R., Hankenson F.C., Lauring A.S., Rohn J.L., and Overbaugh J. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains. J. Virol. 74 (2000) 5754-5761
18. Hansen G.M., Skapura D., and Justice M.J. Genetic profile of insertion mutations in mouse leukemias and lymphomas. Genome Res. 10 (2000) 237-243
19. Jackson M.L., Haines D.M., and Misra V. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases. Vet. Microbiol. 53 (1996) 213-225
20. Johnson C., and Levy L.S. Matrix attachment regions as targets for retroviral integration. Virol. J. (Biomed. Central) 2 (2005) 68
21. Johnson C., Lobelle-Rich P.A., Puetter A., and Levy L.S. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites. J. Virol. 79 (2005) 57-66
22. Kristal B.S., Reinhart T.A., Hoover E.A., and Mullins J.I. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J. Virol. 67 (1993) 4142-4153
23. Lauring A.S., Anderson M.M., and Overbaugh J. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J. Virol. 75 (2001) 8888-8898
24. Levesque K.S., Bonham L., and Levy L.S. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J. Virol. 64 (1990) 3455-3462
25. Levy L.S., and Lobelle-Rich P.A. Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus. J. Virol. 66 (1992) 2885-2892
26. Levy L.S., Lobelle-Rich P.A., and Overbaugh J. Flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1. Oncogene 8 (1993) 1833-1838
27. Levy L.S., Starkey C.R., Prabhu S., and Lobelle-Rich P.A. Cooperating events in lymphomagenesis mediated by feline leukemia virus. Leukemia 11 Suppl. 3 (1997) 239-241
28. Lopez-Ilasaca M., Crespo P., Pellici P.G., Gutkind J.S., and Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275 (1997) 394-397
29. Matsumoto Y., Momoi Y., Watari T., Goitsuka R., Tsujimoto H., and Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology 189 (1992) 745-749
30. Mikkers H., and Berns A. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88 (2003) 53-99
31. Mullins J.I., and Hoover E.A. Molecular aspects of feline leukemia virus pathogenesis. In: Gallo R.C., and Wong-Staal F. (Eds). Retrovirus Biology and Human Disease (1990), Marcel Dekker, Inc., New York 87-116
32. Nagashima N., Hisasue M., Nishigaki K., Miyazawa T., Kano R., and Hasegawa A. In vitro selective suppression of feline myeloid colony formation is attributable to molecularly cloned strain of feline leukemia virus with unique long terminal repeat. Res. Vet. Sci. 78 (2005) 151-154
33. Neil J.C., Fulton R., Rigby M., and Stewart M. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol. 171 (1991) 67-93
34. Nishigaki K., Hanson C., Thompson D., Yugawa T., Hisasue M., Tsujimoto H., and Ruscetti S. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus. J. Virol. 76 (2002) 1527-1532
35. Overbaugh J., and Bangham C.R. Selection forces and constraints on retroviral sequence variation. Science 292 (2001) 1106-1109
36. Phipps A.J., Chen H., Hayes K.A., Roy-Burman P., and Mathes L.E. Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A. J. Virol. 74 (2000) 5796-5801
37. Prabhu S., Lobelle-Rich P.A., and Levy L.S. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication. Virology 263 (1999) 460-470
38. Rezanka L.J., Rojko J.L., and Neil J.C. Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest. 10 (1992) 371-389
39. Rogerson P., Jarrett W., and Mackey L. Epidemiological studies on feline leukaemia virus infection. I. A serological survey in urban cats. Int. J. Cancer 15 (1975) 781-785
40. Rohn J.L., Linenberger M.L., Hoover E.A., and Overbaugh J. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J. Virol. 68 (1994) 2458-2467
41. Rohn J.L., Moser M.S., Gwynn S.R., Baldwin D.N., and Overbaugh J. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant. J. Virol. 72 (1998) 2686-2696
42. Rojko J.L., Hoover E.A., Mathes L.E., Olsen R.G., and Schaller J.P. Pathogenesis of experimental feline leukemia virus infection. J. Natl. Cancer Inst. 63 (1979) 759-768
43. Rojko J.L., and Kociba G.J. Pathogenesis of infection by the feline leukemia virus. J. Am. Vet. Med. Assoc. 199 (1991) 1305-1310
44. Starkey C.R., Lobelle-Rich P.A., Granger S., Brightman B.K., Fan H., and Levy L.S. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus. J. Virol. 72 (1998) 1078-1084
45. Sugai J., Eiden M., Anderson M.M., Van Hoeven N., Meiering C.D., and Overbaugh J. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J. Virol. 75 (2001) 6841-6849
46. Tailor C.S., and Kabat D. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J. Virol. 71 (1997) 9383-9391
47. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., and Neil J.C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J. Virol. 68 (1994) 8296-8303